The CureTalk Weekly RoundUp: CurePanel, Interviews, Diabetes research, Insomnia, and Lung Cancer

Get New Treatments Alerts:

We had a very happening week at CureTalk,

DIAL IN to CurePanel

Curetalk announced its CurePanel, where patients and experts could come together for a live discussion. The web panel would help patients clear their queries regarding their condition as well as get to know about the latest ongoing research in the field.

Jennifer wins the NAMI Pinellas Consumer of the Year Award in 2010.

We interviewed Jennifer Daisybee, a remarkable woman and she talks about her fight with schizoaffective disorder with us. Read here.

Now, for some CureTalk Buzzz…

Crizotinib bound to ATP binding pockets in ALK protein.

Pfizer study data showed crizotinib to prolong survival in ALK positive lung cancer patients. We looked at the mechanism of action of crizotinib and the occurrence of ALK gene mutations.

Diabetes returns after weight loss surgery

Diabetes returned in 1/5 of patients post weight loss surgery.

A new study on diabetes and weight loss surgeries shows that diabetes may return.

New study finds that lung cancer death rates in southern and midwestern states in the US are rising.

An increase in lung cancer deaths was noted among women in the south and Midwest US in a study.

insomnia and cognitive behavioral therapy (CBT-I)

CBT-I is a multi-component intervention for insomnia.

We also curetalked about insomnia and effect of CBT-I, medical malpractice in India, craving for carbohydrates and how to lower diabetes risk by walking more.

Read Pat’s blogs on myeloma here, here, and here.

We had Alicia Sable Hunt write in on The Right Woman For the Job.

We are following multiple myeloma this July so stay tuned for information on myeloma research, drugs, treatments, and patient interviews.

Until then, stay healthy and keep smiling.

Wishing all CureTalk readers a very happy 4th of JULY!!!